![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ATLANTA, GA -- (Marketwire) -- 10/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX) today reported that it received notification from the Nasdaq Stock Market indicating that the staff of the Nasdaq...
ATLANTA, GA -- (Marketwire) -- 10/07/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has...
ATLANTA, GA -- (Marketwire) -- 09/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has...
TORONTO -- (Marketwire) -- 09/02/08 -- BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and...
ATLANTA, GA -- (Marketwire) -- 09/02/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported that it will not...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results for the second quarter and six months ended June 30, 2008. During...
DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
TORONTO , Akamai Technologies Inc. (NASDAQ: AKAM), Starbucks Corporation (NASDAQ: SBUX) and Atherogenics Inc. (NASDAQ: AGIX). To receive free access to these interviews and analyst reports sign up...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 (succinobucol...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its second quarter 2008 financial results on Tuesday, August...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.22 | 0.726552179657 | 30.28 | 31 | 29.27 | 19918 | 30.26496817 | SP |
4 | 1.94 | 6.79271708683 | 28.56 | 31 | 27.9 | 19340 | 29.64970875 | SP |
12 | 2.87 | 10.3872602244 | 27.63 | 31 | 26.985 | 12474 | 29.39089727 | SP |
26 | 7.46 | 32.3784722222 | 23.04 | 31 | 22.158 | 7097 | 28.60005658 | SP |
52 | 5.14 | 20.2681388013 | 25.36 | 31 | 21.82 | 7850 | 27.72087099 | SP |
156 | 5.14 | 20.2681388013 | 25.36 | 31 | 21.82 | 7850 | 27.72087099 | SP |
260 | 5.14 | 20.2681388013 | 25.36 | 31 | 21.82 | 7850 | 27.72087099 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions